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Chronic spontaneous urticaria (CSU) is a common skin disorder
of unknown etiology characterized by spontaneously appearing
wheals and pruritus for six weeks or longer. Recent studies have
supported an autoimmune origin in a population of patients with
CSU. Circulating autoantibodies against the high afﬁnity IgE recep-
tor (FcεRI) and IgE are able to causemast cell degranulation.1 On the
other hand, the possible involvement of the blood coagulation sys-
tem has emerged.2 This notion was supported by moderate in-
creases of several coagulation markers, such as prothrombin
fragment 1þ2 (PF1þ2), ﬁbrin degradation products (FDP) and D-
dimer in correlation with clinical severity, and the efﬁcacy of
anti-coagulants in cases of CSU.3 However, conventional coagula-
tion assays, such as activated partial thromboplastin time (APTT),
that measure only the initiation time of clot formation do not reveal
apparent abnormality in patients with CSU. Since many processes
and proteins are involved in the coagulation, several global coagu-
lation tests have been developed to assess the whole coagulation
process.
We previously revealed the increase of intrinsic coagulation po-
tential in CSU patients, by one of the global coagulation tests, the
APTT clot waveform analysis, and suggested that the activation of
intrinsic coagulation factors may cause mast cell degranulation
through the activation of protease-activating receptor-2 (PAR-2).4
However, an increased coagulation potential shown in the assay
may not necessarily reﬂect the enhancement of intermediate coag-
ulation factors, because the assay assesses the entire coagulation
process from the beginning to ﬁbrinogen-to-ﬁbrin conversion.
We, therefore, cannot exclude possible contributions of signiﬁ-
cantly elevated levels of ﬁbrinogen, which may reﬂect chronic
inﬂammation in CSU, to the hypercoagulable pattern of the assay.
To clarify this, we further analyzed coagulation potentials in CSU,
using calibrated automated thrombography (CAT). This approach
measures the conversion of prothrombin to thrombin without
ﬁbrin generation, and thus eliminates the inﬂuence of ﬁbrinogen
levels (Fig. 1 inset).5 We also investigated the association between
thrombin generation potentials and severities of CSU as well as
the involvement of an autoimmune mechanism shown by autolo-
gous serum skin test (ASST), an in vivo test to demonstrate
wheal-inducing factors in a patient's serum and to assess
autoreactivity.6Peer review under responsibility of Japanese Society of Allergology.
http://dx.doi.org/10.1016/j.alit.2014.07.006
1323-8930/Copyright © 2014, Japanese Society of Allergology. Production and hosting by ElsWe recruited 15 normal healthy individuals and 36 patients
with CSU, who were the same population examined in our previ-
ous report.4 The mean ± SD age of healthy individuals was
37.4 ± 14.0 years (range 27e80) and that of CSU patients was
47.0 ± 18.0 years (range 9e76). No signiﬁcant age difference
was seen between the two groups. All patients were diagnosed
on the basis of the appearance of spontaneous wheals for more
than 6 weeks. The severity of CSU was assessed and described
in the medical record at the time of blood collection, and patients
with CSU were divided into three groups based on an urticaria
activity score7: 10 patients were classiﬁed as mild, 19 as moder-
ate, and 7 as severe. ASST was performed on 25 patients: 10 pa-
tients were positive and 15 negative. All patients were treated
with H1 antagonists. Twenty-ﬁve patients received leukotriene
receptor antagonist, tranexamic acid, H2 receptor antagonists,
and other second-line treatments according to the Japanese
guidelines for the management of urticaria. The study protocol
conformed to the ethical guidelines of the Declaration of Helsinki,
and was approved by the Institutional Review Board at each
institution. All subjects gave written informed consent.Fig. 1. A typical thrombin generation curve of healthy control (thick line) and patients
with chronic spontaneous urticaria. Four parameters extracted from this assay: a,
endogenous thrombin potential (ETP); b, peak height (Peak); c, lag time (Lagtime);
d, time to peak (ttPeak). The inset shows coagulation process that is covered by cali-
brated automated thrombography (black border) and APTT clot formation analysis
(halftone).
evier B.V. All rights reserved.
Fig. 2. Parameters of calibrated automated thrombography. Upper: parameters in healthy controls (open circles) and patients with CSU (ﬁlled circles). Bars indicate means. *p < 0.05,
**p < 0.01, and ***p < 0.001. Middle: correlations between severity of CSU and parameters. Lower: Parameters in ASST-negative (n ¼ 15; open circles) and ASST-positive patients
(n ¼ 10; ﬁlled circles). Bars indicate means.
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thrombin, but also reveal the kinetics of thrombin generation and
the peak activity in time course. The assay was performed in a mi-
crotiter plate ﬂuorometer using dedicated software (Thrombino-
scope). Brieﬂy, coagulation in platelet-poor plasma was triggered
by recalciﬁcation using 5 pM PPP-reagent (Thrombinoscope). The
molar amount of thrombin was calculated from the signal of the
wells and a calibration curve (Fig. 1). The total amount of thrombin
activity, called the endogenous thrombin potential (ETP), was
assessed as the area under the thrombin concentrationetime curve.
The program also calculates parameters including lag time (Lag-
time), peak height (Peak), and time to peak (ttPeak). Mean Rate In-
dex (MRI) was calculated by the formula MRI ¼ Peak/(ttPeak e
Lagtime). Statistical analysis of differences was determined by the
ManneWhitney test. Correlations were calculated according to
Spearman's rank correlation coefﬁcient.
CAT revealed a signiﬁcant elevation of Peak, ETP, and MRI in the
patient group compared with the control group (p < 0.001,
p < 0.01, p < 0.05, respectively) (Fig. 2A). A signiﬁcant correlation
was observed between the severity of CSU and each of CAT param-
eters [Peak (p < 0.01), ETP (p < 0.001), and MRI (p < 0.05)]
(Fig. 2B). In CAT parameters, Peak describes the maximum
thrombin activity and ETP indicates the total amount of thrombin
that is generated throughout the reaction.8,9 MRI reﬂects the ve-
locity of the propagation phase of thrombin generation.10 These
key parameters showed a signiﬁcant elevation in patients with
CSU as well as a signiﬁcant correlation with disease severities,
which strongly suggested an increase of prompt coagulationpotential in patients with CSU regardless of the elevated levels
of ﬁbrinogen.
In our previous study, we showed that the amount of actually
generated thrombin in patients with CSU was not sufﬁcient for
intravascular clotting. The levels of D-dimer and FDP that reﬂect
the amount of actually generated thrombin were elevated but
mostly remained within normal ranges. No signiﬁcant elevation
of the levels of PF 1þ2 that directly reﬂect the amounts of actually
generated thrombinwas observed. These observations suggest that
large-scale thrombin generation (so-called “thrombin burst”) that
leads to ﬁbrinogen cleavage and ﬁbrin polymerization does not
occur in patients with CSU. In the clinical setting, thrombotic events
are not usually a complication of CSU. Furthermore, as CAT revealed
no differences between ASST-positive and -negative groups in any
parameters (Fig. 2C), the hypercoagulable state may develop inde-
pendently of autoreactive mechanisms.
Taken together, coagulation potential is increased in CSU
without the involvement of the elevated ﬁbrinogen levels as well
as autoreactive mechanisms. Subthreshold acceleration of interme-
diate phases of coagulation accompanied by small amount of
thrombin generation may be critical in the pathogenesis of CSU.
Our ﬁndings may lead to the development of new therapeutic stra-
tegies for CSU focusing on targeted inhibition of intermediate coag-
ulation factors.Conﬂict of interest
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